TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
||||
|
|
|||
1. Identity of the issuer or the underlying issuer |
Deltex Medical |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
Yes |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
No |
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
No |
|||
An event changing the breakdown of voting rights |
No |
|||
Other (please specify): |
|
No |
||
3. Full name of person(s) subject to the |
Gartmore Investment Limited |
|||
4. Full name of shareholder(s) |
See attached schedule |
|||
5. Date of the transaction and date on |
10th December 2010 |
|||
6. Date on which issuer notified: |
13th December 2010 |
|||
7. Threshold(s) that is/are crossed or |
11% |
|||
8. Notified details: |
|||||||||||||||
A: Voting rights attached to shares viii, ix |
|||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
|||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
|||||||||||
GB0059337583 |
14,894,815 |
14,894,815 |
14,394,815 |
|
14,394,815 |
|
10.917% |
||||||||
|
|||||||||||||||
|
|||||||||||||||
B: Qualifying Financial Instruments |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|||||||||||
|
|
|
|
|
|||||||||||
|
|||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
||||||||||
|
|
|
|
|
Nominal |
Delta |
|||||||||
|
|
||||||||||||||
|
|||||||||||||||
Total (A+B+C) |
|||||||||||||||
Number of voting rights |
Percentage of voting rights |
||||||||||||||
14,394,815 |
10.917% |
||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
E mail contact RDU@Gartmore.com
|
|
14. Contact name: |
RDU |
|
15. Contact telephone number: |
0207 782 2224 |
|
Note: Annex should only be submitted to the FSA not the issuer |
|
Annex: Notification of major interests in share |
|
|
|
A: Identity of the persons or legal entity subject to the notification obligation |
|
Full name (including legal form of legal entities)
|
Gartmore Investment Limited |
Contact address (registered office for legal entities)
|
Gartmore House, 8 Fenchurch Place, London, EC3M 4PB |
Phone number & email
|
0207 782 2224; RDU@Gartmore.com |
Other useful information (at least legal representative for legal persons)
|
|
|
|
B: Identity of the notifier, if applicable |
|
Full name
|
|
Contact address
|
|
Phone number & email
|
|
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) |
|
|
|
C: Additional information |
|
|
|
For notes on how to complete form TR-1 please see the FSA website. |